The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Achillion Pharmaceuticals Inc. | COM | 00448Q201 | 10,363 | 1,279,340 | SH | DFND | 3 | 1,279,340 | 0 | 0 | |
| Agios Pharmaceuticals Inc. | COM | 00847X104 | 139,948 | 2,649,528 | SH | DFND | 3 | 2,649,528 | 0 | 0 | |
| Alder Biopharmaceuticals Inc. | COM | 014339105 | 55,222 | 1,685,150 | SH | DFND | 3 | 1,685,150 | 0 | 0 | |
| Alexion Pharmaceuticals Inc. | COM | 015351109 | 144,527 | 1,179,428 | SH | DFND | 2 | 1,179,428 | 0 | 0 | |
| Alnylam Pharmaceuticals Inc. | COM | 02043Q107 | 80,749 | 1,191,338 | SH | DFND | 3 | 1,191,338 | 0 | 0 | |
| AveXis, Inc. | COM | 05366U100 | 14,539 | 352,800 | SH | DFND | 3 | 352,800 | 0 | 0 | |
| Celgene Corp | COM | 151020104 | 361,600 | 3,459,298 | SH | DFND | 2 | 3,459,298 | 0 | 0 | |
| Cempra Inc. | COM | 15130J109 | 49,414 | 2,041,900 | SH | DFND | 3 | 2,041,900 | 0 | 0 | |
| Cidara Therapeutics Inc. | COM | 171757107 | 8,551 | 746,824 | SH | DFND | 3 | 746,824 | 0 | 0 | |
| Esperion Therapeutics Inc. | COM | 29664W105 | 18,123 | 1,308,542 | SH | DFND | 3 | 1,308,542 | 0 | 0 | |
| Gilead Sciences Inc. | COM | 375558103 | 219,526 | 2,774,596 | SH | DFND | 1 | 2,774,596 | 0 | 0 | |
| Halozyme Therapeutics Inc. | COM | 40637H109 | 89,148 | 7,379,832 | SH | DFND | 3 | 7,379,832 | 0 | 0 | |
| Incyte Corp. | COM | 45337C102 | 365,828 | 3,879,822 | SH | DFND | 3 | 3,879,822 | 0 | 0 | |
| Intercept Pharmaceuticals Inc. | COM | 45845P108 | 42,089 | 255,719 | SH | DFND | 3 | 255,719 | 0 | 0 | |
| Intra-Cellular Therapies Inc. | COM | 46116X101 | 20,574 | 1,350,000 | SH | DFND | 3 | 1,350,000 | 0 | 0 | |
| Ionis Pharmaceuticals Inc. | COM | 462222100 | 262,459 | 7,163,172 | SH | DFND | 3 | 7,163,172 | 0 | 0 | |
| Juno Therapeutics Inc. | COM | 48205A109 | 42,164 | 1,405,000 | SH | DFND | 3 | 1,405,000 | 0 | 0 | |
| Kite Pharma Inc. | COM | 49803L109 | 44,688 | 800,000 | SH | DFND | 3 | 800,000 | 0 | 0 | |
| MacroGenics Inc. | COM | 556099109 | 43,519 | 1,455,000 | SH | DFND | 3 | 1,455,000 | 0 | 0 | |
| Neurocrine Biosciences Inc. | COM | 64125C109 | 158,075 | 3,121,552 | SH | DFND | 3 | 3,121,552 | 0 | 0 | |
| Novavax Inc. | COM | 670002104 | 17,326 | 8,330,000 | SH | DFND | 3 | 8,330,000 | 0 | 0 | |
| Prothena Corp. PLC | COM | G72800108 | 20,990 | 350,000 | SH | DFND | 3 | 350,000 | 0 | 0 | |
| PTC Therapeutics Inc. | COM | 69366J200 | 16,573 | 1,182,912 | SH | DFND | 3 | 1,182,912 | 0 | 0 | |
| Puma Biotechnology Inc. | COM | 74587V107 | 16,225 | 241,991 | SH | DFND | 3 | 241,991 | 0 | 0 | |
| Radius Health Inc. | COM | 750469207 | 235,854 | 4,360,399 | SH | DFND | 4 | 4,360,399 | 0 | 0 | |
| Regeneron Pharmaceuticals Inc. | COM | 75886F107 | 98,495 | 245,000 | SH | DFND | 2 | 245,000 | 0 | 0 | |
| Sage Therapeutics Inc. | COM | 78667J108 | 47,083 | 1,022,439 | SH | DFND | 3 | 1,022,439 | 0 | 0 | |
| Tesaro Inc. | COM | 881569107 | 97,692 | 974,582 | SH | DFND | 3 | 974,582 | 0 | 0 | |
| Vertex Pharmaceuticals Inc. | COM | 92532F100 | 123,441 | 1,415,445 | SH | DFND | 3 | 1,415,445 | 0 | 0 | |